Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia

dc.contributor.authorBinks, Michael J.
dc.contributor.authorMoberley, Sarah A.
dc.contributor.authorBalloch, Anne
dc.contributor.authorLeach, A. J.
dc.contributor.authorNelson, Sandra
dc.contributor.authorHare, Kim M.
dc.contributor.authorWilson, Cate
dc.contributor.authorNelson, Jane
dc.contributor.authorMorris, Peter
dc.contributor.authorWare, Robert S.
dc.contributor.authorAndrews, Ross
dc.date.accessioned2019-12-18T23:33:40Z
dc.date.available2019-12-18T23:33:40Z
dc.date.issued2018-05-16
dc.date.updated2019-08-04T08:19:06Z
dc.description.abstractBackgroundIndigenous children in Australia's Northern Territory are densely colonised with the pneumococcus within weeks of birth antecedent to a high prevalence of acute lower respiratory infection (ALRI). We assessed the impact of the 23-valent pneumococcal polysaccharide vaccine (23vPPV) in pregnancy against infant ALRI in this setting.MethodsIn an open label, allocation concealed, outcome-assessor blinded, randomised controlled trial conducted in the Northern Territory of Australia, healthy Indigenous women aged 17-39years were randomised to receive the 23vPPV during pregnancy (n=75; 30-36weeks gestation), at birth (n=75), or at 7months post-partum (n=77). Randomisation was stratified by community of residence. In a secondary analysis, we compared the incidence of ALRI hospitalisations and ALRI clinic presentations (ascertained from electronic medical records) among infants of pregnancy vaccinees versus infants of mothers not vaccinated in pregnancy (controls) in the first year of life.ResultsALRI hospitalisation incidence was 12.3 per 100 child-years among infants of pregnancy vaccinees compared with 15.8 per 100 child-years among controls (hazard ratio (HR) 0.77, 95%CI 0.29-2.03). ALRI hospitalisations were more common among remote compared to urban infants (27.7 versus 8.6 per 100 child-years). Stratification by dwelling highlighted a differential antenatal vaccine effect against ALRI hospitalisations (urban HR 2.45, 95%CI 0.60-9.99; remote HR 0.21, 95%CI 0.04-1.08). ALRI clinic presentation incidence was similar among infants of pregnancy vaccinees and controls.ConclusionsIn this small study, antenatal 23vPPV vaccination was not associated with a reduced incidence of infant ALRI hospitalisations or ALRI clinic presentations during the first year of life. A potential differential effect between urban and remote settings warrants further investigation.en_AU
dc.description.sponsorshipThis work was supported by the National Health and Medical Research Council of Australia (project grants 350499, 490320 and scholarship 1017225).en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn2200-6133en_AU
dc.identifier.urihttp://hdl.handle.net/1885/196228
dc.language.isoen_AUen_AU
dc.provenanceThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.en_AU
dc.publisherBioMed Central Ltd.en_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/350499en_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/490320en_AU
dc.relationhttp://purl.org/au-research/grants/nhmrc/1017225en_AU
dc.rights© 2018 The Author(s)en_AU
dc.rights.licensereative Commons Attribution 4.0 International Licenseen_AU
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_AU
dc.sourcePneumoniaen_AU
dc.source.urihttps://pneumonia.biomedcentral.com
dc.subject23-valent pneumococcal polysaccharide vaccineen_AU
dc.subjectPregnancyen_AU
dc.subjectAcute lower respiratory infectionen_AU
dc.subjectAustraliaen_AU
dc.subjectIndigenousen_AU
dc.titleImpact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australiaen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
dcterms.dateAccepted2018-11-20
local.bibliographicCitation.issue13en_AU
local.bibliographicCitation.lastpage9en_AU
local.bibliographicCitation.startpage1en_AU
local.contributor.affiliationBinks, Michael J., Charles Darwin Universityen_AU
local.contributor.affiliationMoberley, Sarah A, Charles Darwin Universityen_AU
local.contributor.affiliationBalloch, Anne, University of Melbourneen_AU
local.contributor.affiliationLeach, A J, Charles Darwin Universityen_AU
local.contributor.affiliationNelson, Sandra, Department of Health and Familiesen_AU
local.contributor.affiliationHare, Kim M, Charles Darwin Universityen_AU
local.contributor.affiliationWilson, Cate, Charles Darwin Universityen_AU
local.contributor.affiliationNelson, Jane, Charles Darwin Universityen_AU
local.contributor.affiliationMorris, Peter, Menzies School of Health Researchen_AU
local.contributor.affiliationWare, Robert S., Griffith Universityen_AU
local.contributor.affiliationAndrews, Ross, College of Health and Medicine, ANUen_AU
local.contributor.authoruidAndrews, Ross, u3882913en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor110203 - Respiratory Diseasesen_AU
local.identifier.absseo920204 - Evaluation of Health Outcomesen_AU
local.identifier.ariespublicationu3102795xPUB2380en_AU
local.identifier.citationvolume10en_AU
local.identifier.doi10.1186/s41479-018-0057-2en_AU
local.identifier.thomsonID4.54273E+11
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01_Binks_Impact_of_the_23-valent_2018.pdf
Size:
1.05 MB
Format:
Adobe Portable Document Format